Trial Profile
The Immunological Basis for Treatment Resistance to Anti-TNF Treatments
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- 06 Nov 2017 Status changed from recruiting to completed.
- 03 Feb 2016 Planned End Date changed from 1 Dec 2016 to 1 Dec 2018 as reported by ClinicalTrials.gov record.
- 03 Feb 2016 Planned primary completion date changed from 1 Jan 2016 to 1 Jan 2018 as reported by ClinicalTrials.gov record.